Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trial
Data de publicación
2013Título da revista
EUROPEAN JOURNAL OF CANCER
Tipo de contido
Publicación de congreso